Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.
about
The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.Cats, Cancer and Comparative OncologyMinimally effective concentration of zoledronic acid to suppress osteoclasts in vitro.Investigation of novel chemotherapeutics for feline oral squamous cell carcinomaCD147 and Cyclooxygenase Expression in Feline Oral Squamous Cell Carcinoma
P2860
Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@en
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@nl
type
label
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@en
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@nl
prefLabel
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@en
Combined zoledronic acid and m ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
Combined zoledronic acid and m ...... e oral squamous cell carcinoma
@en
P2093
C A London
C K Martin
J K Simmons
J L Werbeck
L G Lanigan
M M Carlton
R E Toribio
S P Pillai
W P Dirksen
P2860
P304
P356
10.1111/VCO.12037
P577
2013-05-08T00:00:00Z